1) Terazosin
特拉唑嗪
1.
Preparation of terazosin monolithic osmotic pump tablets and factors of controlled release;
特拉唑嗪单芯渗透泵片研制及其控制释放的因素
2.
Efficacy and Safety of Combination Therapy with Amlodipine Plus Terazosin in Patients with Essential Hypertension;
氨氯地平联合特拉唑嗪治疗原发性高血压的短期疗效和安全性
3.
Terazosin for chronic prostatitis/chronic pelvic pain syndrome:A systematic review of efficacy and adverse effects;
特拉唑嗪治疗慢性前列腺炎/慢性盆腔疼痛综合征的系统评价
2) terazosin hydrochloride
盐酸特拉唑嗪
1.
Determination of terazosin hydrochloride in terazosin hydrochloride tablets by HPLC;
HPLC法测定盐酸特拉唑嗪片中盐酸特拉唑嗪的含量
2.
Determination of the Dissolution of Terazosin Hydrochloride Capsule by HPLC;
HPLC法测定盐酸特拉唑嗪胶囊溶出度
3.
Methods Terazosin hydrochloride was used as internal standard,an Alltima-CN column was used with 0.
方法 以盐酸特拉唑嗪为内标,采用Alltima-CN柱,流动相为 0 0 5mol·L-1磷酸二氢钠溶液(0 5mol·L-1的氢氧化钠溶液调pH至 5 4 ) -乙腈(78∶2 2);检测波长:2 4 4nm。
3) terazosin hydrochloride tablets
盐酸特拉唑嗪片
1.
Comparative study on determination related substance of terazosin hydrochloride tablets by RP-HPLC and TLC;
高效液相色谱法与薄层色谱法测定盐酸特拉唑嗪片有关物质的比较
4) terazosin
盐酸特拉唑嗪
1.
Pharmacokinetics of terazosin in healthy volunteers;
盐酸特拉唑嗪片在健康人体内的药动学研究
2.
Doxazosin and Terazosin were added to 4 mg/d if DBP was > 90 mmHg aft.
目的 评价新一代α_1受体拮抗剂甲磺酸多沙唑嗪的降压疗效及安全性,并与盐酸特拉唑嗪相比较。
3.
Objective:To probe the influence of terazosin on blood rheology, part of blood clotting index and red blood cell biomechanics of MS rats.
本文所提到的药物盐酸特拉唑嗪一方面能降低血脂和血糖,改善红细胞的血液流变学特性,使全血粘度降低。
6) Hytrinex
特拉唑嗪盐酸盐
补充资料：特拉唑嗪
分子式：C19H29ClN5O6
分子量：暂无
CAS号：63590-64-7
性质：暂无
制备方法：暂无
用途：抗高血压药。
分子量：暂无
CAS号：63590-64-7
性质：暂无
制备方法：暂无
用途：抗高血压药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条